Sono-Tek: 3 Key Takeaways for Long-Term Investors
A $10.8 million backlog with most deliveries expected in fiscal 2028 gives long-term investors rare visibility into revenue growth beyond this year.
Sono-Tek reported strong first-half revenue growth of 6% to $10.9 million during its fiscal 2027 earnings call in October 2026. The company attributes this success to a shift towards higher-value production systems in the medical market, which has nearly quadrupled sales in this sector. Medical market revenue surged 289% to $7.1 million during the same period, driven by clients advancing from initial process development to commercial manufacturing.
This transition to higher-value systems results in attractive gross profit margins and longer order visibility for shareholders. Three key takeaways from management include the growth of the forward-deployed engineering (FDE) team, which delivers faster returns on capital than traditional R&D; the expansion of the company's backlog with commitments totaling $10.8 million across clean energy and medical diagnostic lines; and the accelerating order momentum in specialized industrial markets, backed by proprietary system designs and direct customer integration.
The company's strong balance sheet, with $17.7 million in cash and zero debt, positions it well for continued expansion and working capital needs.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
